2nd Circ. Won't Restore Allergan Investors' Breast Implant Suit
A Second Circuit panel on Tuesday declined to revive a class action accusing Allergan Ltd. of downplaying cancer risks linked to the company's breast implants, holding in a summary order that...To view the full article, register now.
Already a subscriber? Click here to view full article